The price has given a consolidation breakout with steadily rising RSI above 70 in weekly time frame. As many pharma stocks are performing in the recent rally like Glenmark, I assume in this business cycle, this could also perform well.
Technically it has given a breakout and still has potential to continue upside.
Disclaimer: Due diligence.
